NCT06967896 Different Models of Tracheal Catheters Are Used for Female Thyroid Glands
| NCT ID | NCT06967896 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Anqing Municipal Hospital |
| Condition | Sore Throat |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-05-25 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2025-05-25 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective:Compare whether the use of tracheal catheters of models 6.0 and 6.5 causes less sore throat in women after thyroid surgery compared with the traditional use of model 7.0 tracheal catheters.Methods: Investigators enrolled 180 female patients with American Society of Anesthesiologists (ASA) physical status I and III, aged 18-65 years, and scheduled for elective undergoing thyroid surgery with general anesthesia. The participants were randomly assigned into three groups(n=60 each group):Group A: Tracheal catheter group with an inner diameter of 6.0mm, Group B: Tracheal catheter group with an inner diameter of 6.5mm, Group C: Tracheal catheter group with an inner diameter of 7.0mm.The incidence and severity of postoperative sore throat were recorded in three groups at 1 h, 6 h, 24 h and 48 h after operation.
Eligibility Criteria
Inclusion Criteria: * Female; * Thyroid surgery should be performed under general anesthesia (GA) at an appropriate time; * ASA grade I-III; * Aged 18-65 years; * BMI less than 35Kg/m2 * In line with ethics, patients voluntarily accept this experiment and sign informed consent. Exclusion Criteria: * Reflux esophagitis, preoperative sore throat, chronic pharyngitis, preoperative hoarseness, use of anticoagulants or corticosteroids, high risk of reflux or aspiration, dysphagia, previous oral or pharyngeal surgical intervention, bleeding disorder, severe heart, lung, liver and kidney dysfunction * Upper respiratory tract infection occurred within 2 weeks before surgery * Unable to insert ET (no more than two intubations) * Patients with hoarseness or sore throat before surgery * Language communication, hearing impairment or brain dysfunction such as stroke, unable to communicate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06967896 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Sore Throat. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06967896 currently recruiting?
Yes, NCT06967896 is actively recruiting participants. Contact the research team at 348092640@qq.com for enrollment information.
Where is the NCT06967896 trial being conducted?
This trial is being conducted at Anqing, China.
Who is sponsoring the NCT06967896 clinical trial?
NCT06967896 is sponsored by Anqing Municipal Hospital. The trial plans to enroll 180 participants.